Clear Harbor Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.85M Sell
2,016
-48
-2% -$48.7K 0.13% 132
2025
Q4
$2.22M Sell
2,064
-17
-0.8% -$16.3K 0.15% 114
2025
Q3
$1.59M Buy
2,081
+3
+0.1% +$2.23K 0.11% 150
2025
Q2
$1.62M Sell
2,078
-378
-15% -$294K 0.12% 130
2025
Q1
$2.03M Buy
2,456
+483
+24% +$402K 0.16% 107
2024
Q4
$1.52M Buy
1,973
+1,400
+244% +$1.16M 0.12% 128
2024
Q3
$508K Hold
573
0.04% 236
2024
Q2
$519K Sell
573
-26
-4% -$20.8K 0.04% 216
2024
Q1
$466K Sell
599
-23
-4% -$16.4K 0.04% 233
2023
Q4
$363K Buy
+622
New +$363K 0.03% 260
2020
Q4
Sell
-372
Closed -$55.1K 544
2020
Q3
$55.1K Buy
+372
New +$57.6K 0.01% 381
2020
Q1
Sell
-372
Closed -$48.9K 506
2019
Q4
$48.9K Buy
+372
New +$43.1K 0.01% 405

Other funds holding LLY

Clear Harbor Asset Management's LLY Position: Q1 2026 in Review

Clear Harbor Asset Management reduced its Eli Lilly (LLY) stake by 2.3% in Q1 2026, selling an estimated $48.7K and leaving 2,016 shares worth $1.85M. The position accounts for 0.13% of the portfolio, ranked #132.

Clear Harbor Asset Management first reported a position in LLY in Q4 2019 and has held it in 12 quarters since. The position peaked at $2.22M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Clear Harbor Asset Management held 2,016 shares of Eli Lilly worth $1.85M as of Q1 2026.
  • Clear Harbor Asset Management sold 48 Eli Lilly shares in Q1 2026, an estimated $48.7K.
  • Eli Lilly made up 0.13% of Clear Harbor Asset Management's portfolio in Q1 2026, its #132 holding.
  • Clear Harbor Asset Management first reported a position in Eli Lilly in Q4 2019 and has held it in 12 quarters since.
  • Clear Harbor Asset Management's Eli Lilly position peaked at $2.22M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Clear Harbor Asset Management's 13F filing for Q1 2026, filed 5 May 2026.